Use of tetrahydrocortisol in glaucoma therapy

Details Use of tetrahydrocortisol in glaucoma therapy Use of tetrahydrocortisol in glaucoma therapy

1986-05-19

1989-09-05

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

514178, 514182, 514913, 514914, A61K 3156

Patent

active

048639125

ABSTRACT:
Pharmaceutical compositions comprising tetrahydrocortisol and method of using same in the control of intraocular pressure are disclosed.

REFERENCES:
patent: 2783226 (1957-02-01), Gould et al.
Chemical Abstracts, vol. 88 (1978), #99603a; Halatek et al.
Chemical Abstracts, vol. 90 (1979); 198072z, Gierkowa et al.
Meyer et al., "Influence of Norethynodrel with Mestranol on Intraocular Pressure in Glaucoma", Arch Ophthal, vol. 75, Jun. 1966.
Treister et al., "Intraocular Pressure and Outflow Facility", Arch. Ophthal, vol. 83, Mar. 1970.
Lamble et al., "Some Effects of Progestogens, Oestrogens and Androgens on the Ocular Tension of Rabbits and Owl Monkeys", Exp. Eye Res., 26, 599-610, (1978).
Southren, et al., "5-beta-dihydrocortisol: Possible Mediator of the Ocular Hypertension in Glaucoma", Investigative Ophthalmology & Visual Science, Mar. 1985, vol. 26, pp. 393-395.
Crum, et al., "A New Class of Steroids Inhibits Angiogenesis in the Presence of Heparin or a Heparin Fragment", Science, Dec. 20, 1985, vol. 230, pp. 1375-1378.

Affiliated with

Also associated with

Rating

Use of tetrahydrocortisol in glaucoma therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of tetrahydrocortisol in glaucoma therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of tetrahydrocortisol in glaucoma therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-243569